Editor-in-Chief
George Perry, University of Texas at San Antonio, USA
Senior Editors
James A. Radosevich, University Of Illinois , USA
Vladimir Torchilin, Northeastern University, USA
Elias Fattal, University of Paris Sud, France
Chang-Guo Zhan, University of Kentucky, USA
Mohamed Azmi Bin Ahmad Hassali, University Sains Malaysia, Malaysia
Antoni Camins-Espuny, University of Barcelona, Spain
Scope of the journal
Scope of the Journal involves Pharmacology, Pharmacognosy, Medicinal chemistry, pharmaceutics and drug delivery, Pharmaceutical analysis, Microbiology, Molecular and Clinical Pharmacology, Biopharmaceutics and drug disposition, and drugs from natural sources, Drug design, Drug delivery, Drug discovery etc. more..
Reversed Phase LC-UV Method Development and Validation for Simultaneous determination of three antiretrovirals: Lamivudine, Zidovudine, Nevirapine and Possible Degradants in a Fixed Dose Pharmaceutical Product
Moji Christianah Adeyeye, Anjali JoshiResearch articleOpen Access
Towards Automated Reasoning for Drug Discovery and Pharmaceutical Business Intelligence
Barry RobsonResearch articleOpen Access
Chemical Composition and Antimicrobial Activity of Essential Oil of Citrus limettioides Tanaka
Neeru Vasudeva, Tanu SharmaResearch articleOpen Access
Single Core Osmotic Pump (SCOP): Development of Single Layer Osmotic controlled release tablet for poorly soluble drug
Geeta M. Patel, Jayendra D. Patel-
Editor-in-Chief
George Perry (born April 12, 1953 in Lompoc, California) is a neuroscientist and Dean of the College of Sciences and Professor of Biology at the University of Texas at San Antonio. Perry is recognized in the field of Alzheimer's disease research particularly for his work on oxidative stress.
Perry's research is primarily focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. He has played a key role in elucidating oxidative damage as the initial cytopathological abnormality in Alzheimer disease. He is currently working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. His current studies focus on two issues: (i) the metabolic basis for the mitochondrial damage restricted to vulnerable neurons; and (ii) the consequences of RNA oxidation on protein synthesis rate and fidelity.